Ledger.Open graph →
SEC Form D · filed February 17, 2022

LexaGene Holdings Inc

Offering
$8.1M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEVERLY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Benjamin Taft · Los Angeles, CADirectorSteven Armstrong · Beverly, MAExecKevin D. Demeritt · Newport Beach, CADirectorMark Froimson · Cleveland, OHExecJohn Philpott · Brentwood, TNDirectorJeffrey M. Mitchell · Beverly, MAExecRonald Redell · TAMPA, FLDirectorSarah Biller · Brentwood, TNDirectorPatrick Townzen · TAMPA, FLExecJoseph M. Caruso · Beverly, MADirectorJane R. Sykes · Beverly, MADirectorKirk Wycoff · Brentwood, TNExecJohn (Jack) F. Regan · Beverly, MAExec · DirectorThomas R. Slezak · Beverly, MADirectorLee Fixel · New York, NYExec · DirectorStephen J. Mastrocola · Beverly, MADirectorRon Lockhart · PAOLI, PAExecLuke V. Carlson · San Francisco, CADirectorGary Cohn · Cleveland, OHExec · DirectorGheorghe Rotar · TAMPA, FLDirectorMatthew Stern · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗